{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:22:24Z","timestamp":1780341744623,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1245\/s10434-024-16588-9","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:23:15Z","timestamp":1733242995000},"page":"2141-2149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgical and Oncologic Outcomes of Primary Tumor Resection in Patients with Small Intestinal Neuroendocrine Tumors: Results from a Single-Center Series Over a 15-Year Period"],"prefix":"10.1245","volume":"32","author":[{"given":"Maria","family":"Danieli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uberto","family":"Fumagalli Romario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Funicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bertani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"10","key":"16588_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589.","journal-title":"JAMA Oncol."},{"issue":"1","key":"16588_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63\u201371. https:\/\/doi.org\/10.1097\/SLA.0b013e31818e4641.","journal-title":"Ann Surg."},{"issue":"2","key":"16588_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1530\/ERC-12-0340","volume":"20","author":"M Ter-Minassian","year":"2013","unstructured":"Ter-Minassian M, Chan JA, Hooshmand SM, et al. Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer. 2013;20(2):187\u201396. https:\/\/doi.org\/10.1530\/ERC-12-0340.","journal-title":"Endocr Relat Cancer."},{"issue":"7","key":"16588_CR4","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00268-010-0519-z","volume":"34","author":"K Landerholm","year":"2010","unstructured":"Landerholm K, Falkmer S, J\u00e4rhult J. Epidemiology of small bowel carcinoids in a defined population. World J Surg. 2010;34(7):1500\u20135. https:\/\/doi.org\/10.1007\/s00268-010-0519-z.","journal-title":"World J Surg."},{"issue":"9","key":"16588_CR5","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1245\/s10434-020-08787-x","volume":"27","author":"A Gangi","year":"2020","unstructured":"Gangi A, Howe JR. The landmark series: neuroendocrine tumor liver metastases. Ann Surg Oncol. 2020;27(9):3270\u201380. https:\/\/doi.org\/10.1245\/s10434-020-08787-x.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"16588_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.surg.2018.04.070","volume":"165","author":"AT Scott","year":"2019","unstructured":"Scott AT, Breheny PJ, Keck KJ, et al. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs). Surgery. 2019;165(1):166\u201375. https:\/\/doi.org\/10.1016\/j.surg.2018.04.070.","journal-title":"Surgery."},{"issue":"1","key":"16588_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197(1):29\u201337. https:\/\/doi.org\/10.1016\/S1072-7515(03)00230-8.","journal-title":"J Am Coll Surg."},{"issue":"12","key":"16588_CR8","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","volume":"17","author":"SC Mayo","year":"2010","unstructured":"Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17(12):3129\u201336. https:\/\/doi.org\/10.1245\/s10434-010-1154-5.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"16588_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli S, Bartsch DK, Capdevila J, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255\u201365. https:\/\/doi.org\/10.1159\/000464292.","journal-title":"Neuroendocrinology."},{"key":"16588_CR10","doi-asserted-by":"publisher","unstructured":"Daskalakis K, Tsolakis AV. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider? World J Gastroenterol. 2018;24(29):3201-3203. https:\/\/doi.org\/10.3748\/wjg.v24.i29.3201.","DOI":"10.3748\/wjg.v24.i29.3201"},{"issue":"4","key":"16588_CR11","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1245\/s10434-023-14637-3","volume":"31","author":"A Nigam","year":"2024","unstructured":"Nigam A, Li JWY, Fiasconaro M, et al. Morbidity and outcomes of primary tumor management in patients with widely metastatic well-differentiated small bowel neuroendocrine tumors. Ann Surg Oncol. 2024;31(4):2337\u201348. https:\/\/doi.org\/10.1245\/s10434-023-14637-3.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"16588_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B, et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer. 2009;16(3):885\u201394. https:\/\/doi.org\/10.1677\/ERC-09-0042.","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"16588_CR13","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/SLA.0000000000002809","volume":"270","author":"A Lewis","year":"2019","unstructured":"Lewis A, Raoof M, Ituarte PHG, et al. Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment. Ann Surg. 2019;270(6):1131\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000002809.","journal-title":"Ann Surg."},{"key":"16588_CR14","doi-asserted-by":"publisher","unstructured":"Givi B, Pommier SJ, Thompson AK, et al. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery. 2006;140(6):891-7; discussion 897-8. https:\/\/doi.org\/10.1016\/j.surg.2006.07.033.","DOI":"10.1016\/j.surg.2006.07.033"},{"issue":"8","key":"16588_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstr\u00f6m T, Ohrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg. 2002;26(8):991\u20137. https:\/\/doi.org\/10.1007\/s00268-002-6630-z.","journal-title":"World J Surg."},{"issue":"5","key":"16588_CR16","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1097\/SLA.0000000000004647","volume":"276","author":"S Bennett","year":"2022","unstructured":"Bennett S, Coburn N, Law C, et al. Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis. Ann Surg. 2022;276(5):e450\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000004647.","journal-title":"Ann Surg."},{"issue":"7","key":"16588_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13146","volume":"34","author":"S Grozinsky-Glasberg","year":"2022","unstructured":"Grozinsky-Glasberg S, Davar J, Hofland J, et al. European neuroendocrine tumor society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease. J Neuroendocrinol. 2022;34(7):e13146. https:\/\/doi.org\/10.1111\/jne.13146.","journal-title":"J Neuroendocrinol."},{"issue":"5","key":"16588_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1159\/000441423","volume":"103","author":"S Lardi\u00e8re-Deguelte","year":"2016","unstructured":"Lardi\u00e8re-Deguelte S, de Mestier L, App\u00e9r\u00e9 F, et al. Toward a preoperative classification of lymph node metastases in patients with small intestinal neuroendocrine tumors in the era of intestinal-sparing surgery. Neuroendocrinology. 2016;103(5):552\u20139. https:\/\/doi.org\/10.1159\/000441423.","journal-title":"Neuroendocrinology."},{"issue":"5","key":"16588_CR19","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s13304-022-01251-3","volume":"74","author":"E Bertani","year":"2022","unstructured":"Bertani E, Zugni F, Radice D, et al. Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors. Updates Surg. 2022;74(5):1697\u2013704. https:\/\/doi.org\/10.1007\/s13304-022-01251-3.","journal-title":"Updates Surg."},{"key":"16588_CR20","volume-title":"WHO classification of tumors of the digestive system","author":"FT Bosman","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumors of the digestive system. 4th edn. Geneva: World Health Organization; 2010.","edition":"4"},{"key":"16588_CR21","unstructured":"Amin MB, Edge SB, Greene FL et al. (eds). AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017"},{"issue":"11","key":"16588_CR22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.8842","volume":"99","author":"G Capurso","year":"2012","unstructured":"Capurso G, Rinzivillo M, Bettini R, et al. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg. 2012;99(11):1480\u20136. https:\/\/doi.org\/10.1002\/bjs.8842.","journal-title":"Br J Surg."},{"issue":"3","key":"16588_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ecl.2018.04.012","volume":"47","author":"AR Hayes","year":"2018","unstructured":"Hayes AR, Davar J, Caplin ME. Carcinoid heart disease: a review. Endocrinol Metab Clin North Am. 2018;47(3):671\u201382. https:\/\/doi.org\/10.1016\/j.ecl.2018.04.012.","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"1","key":"16588_CR24","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/SLA.0000000000003237","volume":"274","author":"D Kaemmerer","year":"2021","unstructured":"Kaemmerer D, Twrznik M, Kulkarni HR, et al. Prior resection of the primary tumor prolongs survival after peptide receptor radionuclide therapy of advanced neuroendocrine neoplasms. Ann Surg. 2021;274(1):e45\u201353. https:\/\/doi.org\/10.1097\/SLA.0000000000003237.","journal-title":"Ann Surg."},{"issue":"10446","key":"16588_CR25","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"S Singh","year":"2024","unstructured":"Singh S, Halperin D, Myrehaug S, et al. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2\u20133, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024;403(10446):2807\u201317. https:\/\/doi.org\/10.1016\/S0140-6736(24)00701-3.2024;42(3Suppl):LBA588.doi:10.1200\/jco.2024.42.3_suppl.lba588.","journal-title":"Lancet."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16588-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16588-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16588-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T13:39:07Z","timestamp":1739194747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16588-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["16588"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16588-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Maria Danieli, Uberto Fumagalli Romario, Davide Radice, Simonetta Pozzi, Francesca Spada, Luigi Funicelli, Nicola Fazio, and Emilio Bertani have no conflicts of interest to declare that may be relevant to the contents of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DISCLOSURE"}}]}}